The present invention relates to N-acetyl glycol split heparin molecules conjugated with biotin having the following formula (I)wherein the meanings of the substituents are disclosed in the description.The present invention also relates to such compounds for use as medicaments, in particular for the treatment of diseases and disorders associated with heparanase activity, and to pharmaceutical compositions comprising the same.
